サマリー

ベーチェット病治療薬の世界市場 2022-2026 年
Technavioはベーチェット病治療薬市場を監視しており、2022-2026年の間に2億8172万ドルの成長が見込まれ、予測期間中にCAGR 6.68%で減速しています。当レポートでは、ベーチェット病治療薬市場について、全体的な分析、市場規模と予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを提供しています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境について最新の分析を提供しています。市場は、適応外薬の多用、特効薬指定、希少疾患に対する研究費の増加によって牽引されています。
ベーチェット病治療薬市場の分析には、製品セグメントと地理的展望が含まれます。
Technavioのベーチェット病治療薬市場は、以下のように区分されています。
製品別
- 低分子化合物
- 生物学的製剤
地理的状況別
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、希少疾患に対する認識の高まりが、今後数年間のベーチェット病治療薬市場の成長を促進する主要な理由の1つであると特定しています。また、戦略的提携や新規治療薬の登場は、市場の大きな需要につながると考えられます。
Technavio社は、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。ベーチェット病治療薬市場に関する当レポートは、以下の分野を対象としています。
- ベーチェット病治療薬市場のサイジング
- ベーチェット病治療薬市場の予測
- ベーチェット病治療薬市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、AbbVie社、Amgen社、F. Hoffmann La Roche Ltd.、Johnson and Johnson、三菱ケミカルホールディングス株式会社、Novartis AG、Pfizer社、武田薬品工業株式会社、Viatris社を含むいくつかの主要ベーチェット病の治療薬市場ベンダーについての詳細分析を提供しています。Ltd.、武田薬品工業株式会社、株式会社エフ・ホフマン・ラ・ロシュ、三菱ケミカルホールディングス株式会社、ノバルティス株式会社、ファイザー株式会社、株式会社ヴィアトリスまた、ベーチェット病治療薬市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/behcet-s-disease-therapeutics-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細なイメージを提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Product
o 5.1 Market segments
o Exhibit 24: Chart on Product - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
o 5.2 Comparison by Product
o Exhibit 26: Chart on Comparison by Product
o Exhibit 27: Data Table on Comparison by Product
o 5.3 Small molecules - Market size and forecast 2021-2026
o Exhibit 28: Chart on Small molecules - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Small molecules - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Small molecules - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Small molecules - Year-over-year growth 2021-2026 (%)
o 5.4 Biologics - Market size and forecast 2021-2026
o Exhibit 32: Chart on Biologics - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Biologics - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Biologics - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Biologics - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Product
o Exhibit 36: Market opportunity by Product ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Canada - Market size and forecast 2021-2026
o Exhibit 62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.9 UK - Market size and forecast 2021-2026
o Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.10 Germany - Market size and forecast 2021-2026
o Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.11 Japan - Market size and forecast 2021-2026
o Exhibit 74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Japan - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Japan - Year-over-year growth 2021-2026 (%)
o 7.12 France - Market size and forecast 2021-2026
o Exhibit 78: Chart on France - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on France - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on France - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on France - Year-over-year growth 2021-2026 (%)
o 7.13 Market opportunity By Geographical Landscape
o Exhibit 82: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 83: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 85: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 86: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 87: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 88: Matrix on vendor position and classification
o 10.3 AbbVie Inc.
o Exhibit 89: AbbVie Inc. - Overview
o Exhibit 90: AbbVie Inc. - Product / Service
o Exhibit 91: AbbVie Inc. - Key offerings
o 10.4 Amgen Inc.
o Exhibit 92: Amgen Inc. - Overview
o Exhibit 93: Amgen Inc. - Product / Service
o Exhibit 94: Amgen Inc. - Key offerings
o 10.5 F. Hoffmann La Roche Ltd.
o Exhibit 95: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 96: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 97: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 98: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 99: F. Hoffmann La Roche Ltd. - Segment focus
o 10.6 Johnson and Johnson
o Exhibit 100: Johnson and Johnson - Overview
o Exhibit 101: Johnson and Johnson - Business segments
o Exhibit 102: Johnson and Johnson - Key news
o Exhibit 103: Johnson and Johnson - Key offerings
o Exhibit 104: Johnson and Johnson - Segment focus
o 10.7 Mitsubishi Chemical Holdings Corp.
o Exhibit 105: Mitsubishi Chemical Holdings Corp. - Overview
o Exhibit 106: Mitsubishi Chemical Holdings Corp. - Business segments
o Exhibit 107: Mitsubishi Chemical Holdings Corp. - Key offerings
o Exhibit 108: Mitsubishi Chemical Holdings Corp. - Segment focus
o 10.8 Novartis AG
o Exhibit 109: Novartis AG - Overview
o Exhibit 110: Novartis AG - Business segments
o Exhibit 111: Novartis AG - Key offerings
o Exhibit 112: Novartis AG - Segment focus
o 10.9 Pfizer Inc.
o Exhibit 113: Pfizer Inc. - Overview
o Exhibit 114: Pfizer Inc. - Product / Service
o Exhibit 115: Pfizer Inc. - Key news
o Exhibit 116: Pfizer Inc. - Key offerings
o 10.10 Takeda Pharmaceutical Co. Ltd.
o Exhibit 117: Takeda Pharmaceutical Co. Ltd. - Overview
o Exhibit 118: Takeda Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 119: Takeda Pharmaceutical Co. Ltd. - Key news
o Exhibit 120: Takeda Pharmaceutical Co. Ltd. - Key offerings
o 10.11 Viatris Inc.
o Exhibit 121: Viatris Inc. - Overview
o Exhibit 122: Viatris Inc. - Business segments
o Exhibit 123: Viatris Inc. - Key offerings
o Exhibit 124: Viatris Inc. - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 125: Inclusions checklist
o Exhibit 126: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 127: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 128: Research methodology
o Exhibit 129: Validation techniques employed for market sizing
o Exhibit 130: Information sources
o 11.5 List of abbreviations
o Exhibit 131: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Product - Market share 2021-2026 (%)
Exhibits25: Data Table on Product - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Product
Exhibits27: Data Table on Comparison by Product
Exhibits28: Chart on Small molecules - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Small molecules - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Small molecules - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Small molecules - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Biologics - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Biologics - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Biologics - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Biologics - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Product ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Japan - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on France - Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ million)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: AbbVie Inc. - Overview
Exhibits90: AbbVie Inc. - Product / Service
Exhibits91: AbbVie Inc. - Key offerings
Exhibits92: Amgen Inc. - Overview
Exhibits93: Amgen Inc. - Product / Service
Exhibits94: Amgen Inc. - Key offerings
Exhibits95: F. Hoffmann La Roche Ltd. - Overview
Exhibits96: F. Hoffmann La Roche Ltd. - Business segments
Exhibits97: F. Hoffmann La Roche Ltd. - Key news
Exhibits98: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits99: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits100: Johnson and Johnson - Overview
Exhibits101: Johnson and Johnson - Business segments
Exhibits102: Johnson and Johnson - Key news
Exhibits103: Johnson and Johnson - Key offerings
Exhibits104: Johnson and Johnson - Segment focus
Exhibits105: Mitsubishi Chemical Holdings Corp. - Overview
Exhibits106: Mitsubishi Chemical Holdings Corp. - Business segments
Exhibits107: Mitsubishi Chemical Holdings Corp. - Key offerings
Exhibits108: Mitsubishi Chemical Holdings Corp. - Segment focus
Exhibits109: Novartis AG - Overview
Exhibits110: Novartis AG - Business segments
Exhibits111: Novartis AG - Key offerings
Exhibits112: Novartis AG - Segment focus
Exhibits113: Pfizer Inc. - Overview
Exhibits114: Pfizer Inc. - Product / Service
Exhibits115: Pfizer Inc. - Key news
Exhibits116: Pfizer Inc. - Key offerings
Exhibits117: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits118: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits119: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits120: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits121: Viatris Inc. - Overview
Exhibits122: Viatris Inc. - Business segments
Exhibits123: Viatris Inc. - Key offerings
Exhibits124: Viatris Inc. - Segment focus
Exhibits125: Inclusions checklist
Exhibits126: Exclusions checklist
Exhibits127: Currency conversion rates for US$
Exhibits128: Research methodology
Exhibits129: Validation techniques employed for market sizing
Exhibits130: Information sources
Exhibits131: List of abbreviations